Northern Trust
OMIC

Northern Trust’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Northern Trust’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,679
Closed -$41.3K – 4491
2024
Q1 		$41.3K Hold
2,679
– – ﹤0.01% 4253
2023
Q4 		$37K Hold
2,679
– – ﹤0.01% 4283
2023
Q3 		$30.6K Hold
2,679
– – ﹤0.01% 4262
2023
Q2 		$66.7K Sell
2,679
-13,563
-84% -$397K ﹤0.01% 4143
2023
Q1 		$590K Buy
16,242
+427
+3% +$26.2K ﹤0.01% 3397
2022
Q4 		$954K Sell
15,815
-235
-1% -$15.7K ﹤0.01% 3276
2022
Q3 		$1.2M Buy
16,050
+2,368
+17% +$247K ﹤0.01% 3251
2022
Q2 		$1.57M Buy
13,682
+1,529
+13% +$179K ﹤0.01% 3189
2022
Q1 		$2.3M Buy
12,153
+7,856
+183% +$1.82M ﹤0.01% 3029
2021
Q4 		$1.49M Buy
4,297
+831
+24% +$322K ﹤0.01% 3369
2021
Q3 		$1.16M Buy
+3,466
New +$1.78M ﹤0.01% 3502

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Northern Trust's OMIC Position: Q2 2024 in Review

Northern Trust sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2024, closing a stake of 2,679 shares — an estimated $41.3K sold.

Northern Trust first reported a position in OMIC in Q3 2021 and held it in 11 quarters. The position peaked at $2.3M in Q1 2022. 24 funds tracked by Wall St. Rank hold OMIC as of Q2 2024.

  • Northern Trust reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Northern Trust sold 2,679 Singular Genomics Systems, Inc. Common Stock shares in Q2 2024, an estimated $41.3K.
  • Northern Trust first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Northern Trust's Singular Genomics Systems, Inc. Common Stock position peaked at $2.3M in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2024.

Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.